Open access
50
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
Wenyu Ye1 Lilly Suzhou Pharmaceutical Co, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
, Haya Ascher-Svanum2 Eli Lilly and Company, Indianapolis, IN, USA
, Yuka Tanji3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe
, Jennifer A Flynn3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe
& Michihiro Takahashi3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe;4 Terauchi-Takahashi Psychiatric Clinic, Ashiya, Japan
Pages 611-617
|
Published online: 14 Dec 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.